NeoGenomics' Liquid Biopsy Subsidiary Inivata Announces Clinical Collaboration With Princess Margaret Cancer Center for the Use of Its Liquid Biopsy Assays Oct 19, 2021
NeoGenomics' Liquid Biopsy Subsidiary Inivata and Collaborators to Present Data that Further Validate the Application of its RaDaR(TM) MRD and InVisionFirst(R)-Lung Assays at the ESMO Congress 2021 Sep 9, 2021
NeoGenomics to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference Sep 1, 2021
NeoGenomics Completes Inivata Acquisition - Combining Best-In-Class Liquid Biopsy Technology with Leading Community Oncology Platform Jun 18, 2021
NeoGenomics To Participate Virtually In Multiple Upcoming Institutional Investor Conferences May 27, 2021
